Impaired Action of Levcromakalim on ATP-Sensitive K + Channels in Mesenteric Artery Cells From Spontaneously Hypertensive Rats
- 1 June 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 27 (6) , 1234-1239
- https://doi.org/10.1161/01.hyp.27.6.1234
Abstract
The purpose of the present study was to test the hypothesis that properties of ATP-sensitive K+ channels are altered in arterial smooth muscle cells of hypertensive rats. Using a patch-clamp technique, we compared effects of a K+ channel opener, levcromakalim, on membrane currents in mesenteric artery cells from adult Wistar Kyoto rats (WKY) and age-matched spontaneously hypertensive rats (SHR) treated or not treated with hydralazine. Blood pressure was significantly higher in SHR than in WKY or hydralazine-treated SHR. Levcromakalim evoked a time-independent and voltage-insensitive current in a dose-dependent manner in the whole-cell clamp configuration. The reversal potential of the evoked current depended on extracellular K+ concentration. Application of 3 μmol/L glibenclamide, a specific blocker of ATP-sensitive K+ channels, abolished the levcromakalim-evoked current; however, the current was unaffected by either 1 mmol/L tetraethylammonium or 0.3 μmol/L charybdotoxin. These results suggest t...Keywords
This publication has 19 references indexed in Scilit:
- Calcium current in smooth muscle cells from normotensive and genetically hypertensive rats.Hypertension, 1994
- Remission of high blood pressure reverses arterial potassium channel alterations.Hypertension, 1994
- Decreased ATP sensitivity of a K+ channel and enhanced vascular smooth muscle relaxation in genetically hypertensive ratsJournal Of Hypertension, 1993
- Preferential small arteriolar vasodilation by the potassium channel opener, BRL 38227, in conscious spontaneously hypertensive ratsEuropean Journal of Pharmacology, 1992
- A Ca(2+)-dependent K+ current is enhanced in arterial membranes of hypertensive rats.Hypertension, 1992
- Recent progress in potassium channel opener pharmacologyBiochemical Pharmacology, 1992
- Clinical Studies with the Potassium Channel Activator Cromakalim in Normotensive and Hypertensive SubjectsJournal of Cardiovascular Pharmacology, 1990
- Moving together: K+ channel openersand ATP-sensitive K+ channelsTrends in Pharmacological Sciences, 1989
- A Ca2+-activated K+ channel from rabbit aorta: modulation by cromakalimEuropean Journal of Pharmacology, 1989
- Hyperpolarizing Vasodilators Activate ATP-sensitive K + Channels in Arterial Smooth MuscleScience, 1989